Literature DB >> 20700736

Rhinosporidiosis isolated to the distal clavicle: a rare presentation clinicoradiologically mimicking a bone tumor.

Pallavi Vishnu Suryawanshi1, Bharat Rekhi, Saral Desai, Subhash M Desai, Shashi L Juvekar, Nirmala Ajit Jambhekar.   

Abstract

Rhinosporidiosis is a chronic granulomatous disease caused by Rhinosporidium seeberi, which commonly affects young men and predominantly involves the mucous membranes of the nose, nasopharynx and eyes. Involvement of extranasal sites including bone has been reported, but rarely. We present a case of a 32-year-old farmer, who presented with a non-tender, fixed swelling over his right shoulder. Radiography and CT imaging showed an expansile, lytic, destructive lesion involving the lateral end of the right clavicle with soft tissue extension. The clinicoradiological impression was that of a primary bone tumor. Biopsy and wide excision of the lesion revealed features of rhinosporidiosis. There were no mucocutaneous lesions. Involvement of bone without associated mucocutaneous lesions is exceedingly rare in rhinosporidiosis. Involvement of the clavicle, as seen in the present case, has not been reported in the English language-peer reviewed literature, to the best of our knowledge.

Entities:  

Mesh:

Year:  2010        PMID: 20700736     DOI: 10.1007/s00256-010-0996-z

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  13 in total

1.  Fine needle aspiration diagnosis of subcutaneous and osteolytic rhinosporidiosis.

Authors:  V S Kavishwar; L P Naik; I M Vora
Journal:  Cytopathology       Date:  1998-06       Impact factor: 2.073

2.  Rhinosporidioma of bone: diagnosis by fine needle aspiration.

Authors:  S A Pai; K N Naresh; S R Shinde; A M Borges
Journal:  Acta Cytol       Date:  1996 Jul-Aug       Impact factor: 2.319

3.  Disseminated rhinosporidiosis.

Authors:  M S Ho; B K Tay
Journal:  Ann Acad Med Singapore       Date:  1986-01       Impact factor: 2.473

4.  Subcutaneous and osteolytic rhinosporidiosis.

Authors:  S Gokhale; V C Ohri; H Subramanya; P S Reddy; S C Sharma
Journal:  Indian J Pathol Microbiol       Date:  1997-01       Impact factor: 0.740

5.  Medical therapy of rhinosporidiosis with dapsone.

Authors:  A Job; S Venkateswaran; M Mathan; H Krishnaswami; R Raman
Journal:  J Laryngol Otol       Date:  1993-09       Impact factor: 1.469

6.  Rhinosporidiosis. Report of a case with an unusual presentation with bony involvement.

Authors:  B K Adiga; N Singh; V K Arora; A Bhatia; A K Jain
Journal:  Acta Cytol       Date:  1997 May-Jun       Impact factor: 2.319

7.  Disseminated rhinosporidiosis destroying the talus: a case report.

Authors:  R Amritanand; M Nithyananth; V M Cherian; K Venkatesh; A Shah
Journal:  J Orthop Surg (Hong Kong)       Date:  2008-04       Impact factor: 1.118

8.  Rhinosporidiosis of parotid duct.

Authors:  B Sivapathasundharam; T R Saraswathi; K Manjunath; G Sriram
Journal:  Indian J Dent Res       Date:  2009 Jul-Sep

9.  Recent advances in rhinosporidiosis and Rhinosporidium seeberi.

Authors:  S N Arseculeratne
Journal:  Indian J Med Microbiol       Date:  2002 Jul-Sep       Impact factor: 0.985

10.  Cytologic and differential diagnosis of rhinosporidiosis.

Authors:  S Gori; A Scasso
Journal:  Acta Cytol       Date:  1994 May-Jun       Impact factor: 2.319

View more
  3 in total

1.  Rare case of disseminated rhinosporidiosis with chronic osteomyelitis of the calcaneum treated by a simple technique of negative pressure wound therapy.

Authors:  Jayakrishnan Kelamangalathu Narayana Kurup; Ravitheja Singasani; Simanchal P Mohanty
Journal:  BMJ Case Rep       Date:  2017-10-15

2.  Osseous involvement in rhinosporidiosis.

Authors:  Atin Kumar Kundu; Satyendra Phuljhele; Mantu Jain; Raman Kumar Srivastava
Journal:  Indian J Orthop       Date:  2013-09       Impact factor: 1.251

3.  Calvarial involvement in disseminated rhinosporidiosis - A case report and literature review.

Authors:  B Dewangan; R Naik; R Membally; M Dewangan
Journal:  J Postgrad Med       Date:  2020 Jan-Mar       Impact factor: 1.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.